Scienta
June 22, 2026
5B
Type: Start-Up Stadium Session
Focus Area:
Immunology
Scienta is a techbio company founded in 2021 by Camille Bouget, Vincent Bouget and Julien Duquesne to boost drug development in immunology & inflammation. Its AI platform, EVA, is the first cross-species, multimodal foundation model for I&I. EVA learns from ImmunAtlas, a proprietary database of 600K+ patient profiles and 3B+ biological data points across 30+ diseases. EVA enables target discovery, cross-species translation and patient stratification, predicting human efficacy ahead of first in human administration. It achieved state-of-the-art results across 39 immune-specific benchmarks, validated through biopharma partnerships and peer-reviewed publications. The company has raised €6.5M since its inception.
Company HQ City:
Paris
Company HQ State:
Île-de-France
Company HQ Country:
France
Year Founded:
2021
CEO
Camille Bouget
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}